Brineura Kit
Product Images NDC 68135-811
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Brineura (NDC 68135-811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biomarin Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Intraventricular Electrolytes Injection Vial (Brineura 10)
Admin Kit (Brineura 11)
Figure 2 (Brineura 2)
Figure 3 (Brineura 3)
Figure 4 (Brineura 4)
Figure 5 (Brineura 5)
Figure 6 (Brineura 6)
Figure 7 (Brineura 7)
Carton (Brineura 8)
This appears to be the description of Brineura, a drug used for intraventricular infusions containing cerliponase alfa in a 150mg/5mL dosage stored at 20°C + 5°C. The package contains an Administration Kit and must be used as prescribed. It is advised to store Brineura upright in its original package and thaw at room temperature before use.*
Brineura Vial (Brineura 9)
This is a label from a pharmaceutical company called BioMarin. It contains information on the administration and dosage of the drug Brineura (cerliponase alfa), which should be used for intraventricular infusion only. It also provides instructions to thaw the drug at room temperature and to use it immediately since it is for single-dose only. The location of the company is in Novato, California, and it is licensed under US License No.1649. The other text seems to be partially corrupted and not-readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.